BPC-157
aka Body Protection Compound 157 · PL 14736
Healing & Recovery research-only
Mechanism
Pentadecapeptide derived from a gastric protective protein. Studied for tendon/ligament healing, GI tract repair, and angiogenesis via VEGFR2 pathway interaction.
Studied uses
- tendon and ligament injury recovery
- gastrointestinal ulcer healing (animal studies)
- post-surgical recovery (research only)
Identification
| CAS number | 137525-51-0 |
|---|---|
| Molecular formula | C62H98N16O22 |
| Sequence | GEPPPGKPADDAGLV |
| Typical dose | 250–500 mcg/day subcutaneous (research only — not FDA approved for human use) |
| Half-life | ~30 minutes (parenteral) |
Safety
Not FDA-approved for human therapeutic use. WADA does not currently prohibit BPC-157 but research-use only status applies in most jurisdictions.
Vendors selling BPC-157
No vendor listings on file yet.
Research
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Sikiric P, Seiwerth S, et al. · Current Pharmaceutical Design (2011) · review · evidence B
Review of BPC-157 effects on the GI tract; foundational reference for the molecule's protective and healing properties in animal models.
source → Pentadecapeptide BPC 157 enhances the healing process of damaged Achilles tendon in rats
Krivic A, Anic T, et al. · Journal of Orthopaedic Research (2010) · animal · evidence C
Animal model showing accelerated Achilles tendon healing with BPC-157 administration.
source →